Previously, brevilin A has been identified as a janus kinases (JAKs) inhibitor, and exhibits a potent repression on signal transducer and activator of transcription 3 (STAT3) signaling and cancer cell growth (Chen et al., 2013; Khan et al., 2020). The gene discussed is STAT3; the disease is cancer.